Literature DB >> 8665680

Use of medians and "average of normals" of patients' data for assessment of long-term analytical stability.

J A Lott1, D A Smith, L C Mitchell, M L Moeschberger.   

Abstract

Using results from patients, we studied several methods for long-term (years) monitoring of the analytical stability of various chemistry tests. For each test, we obtained on a bimonthly basis histograms of > or = 200 to approximately 2000 data points and determined the median, mean, and mean of those data points in the reference range ("average of normal" or AON). Examining approximately 4 years' data, we found that the medians and AON are extremely stable for most tests, and that all observed shifts in the medians or in the AON could be explained by expected or unexpected changes in the laboratory. The means and peak values of the Erlang (gamma) distribution were less useful, owing to shifts caused by extreme outliers, especially for enzymes in serum. We assumed that the underlying patient population and testing patterns were stable. We recommend the use of medians or the AON of patients' data under defined conditions for monitoring the long-term analytical stability of certain tests involving serum or whole blood.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8665680

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  Moving Rate of Positive Patient Results as a Quality Control Tool for High-Sensitivity Cardiac Troponin T Assays.

Authors:  Tingting Li; Shunwang Cao; Yi Wang; Yujuan Xiong; Yuting He; Peifeng Ke; Xianzhang Huang
Journal:  Ann Lab Med       Date:  2020-08-25       Impact factor: 3.464

2.  Mean platelet size related to glycoprotein-specific autoantibodies and platelet-associated IgG.

Authors:  K Javela; R Kekomäki
Journal:  Int J Lab Hematol       Date:  2007-12       Impact factor: 2.877

3.  Failure of internal quality control in detecting significant reagent lot shift in serum creatinine measurement.

Authors:  Xiaoting Chen; Jia Wang; Wei Zhang; Erfu Xie; Bingfeng Zhang; Hua-Guo Xu
Journal:  J Clin Lab Anal       Date:  2019-08-02       Impact factor: 2.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.